跳转至内容
Merck
CN

83580

Sigma-Aldrich

利血平

crystallized, ≥99.0% (HPLC)

别名:

(3β, 16β, 17α, 18β, 20α)-11,17-二甲氧基-18-[(3,4,5-三甲氧基苯甲酰基)氧基]育亨烷-16-羧酸甲酯

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C33H40N2O9
CAS号:
分子量:
608.68
Beilstein:
102014
EC 号:
MDL编号:
UNSPSC代码:
12352200
PubChem化学物质编号:
NACRES:
NA.77

检测方案

≥99.0% (HPLC)

形式

solid

旋光性

[α]20/D −123±3°, c = 1% in chloroform

质量

crystallized

mp

~265 °C (dec.)

SMILES字符串

CO[C@H]1[C@@H](C[C@@H]2CN3CCc4c([nH]c5cc(OC)ccc45)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)c6cc(OC)c(OC)c(OC)c6

InChI

1S/C33H40N2O9/c1-38-19-7-8-20-21-9-10-35-16-18-13-27(44-32(36)17-11-25(39-2)30(41-4)26(12-17)40-3)31(42-5)28(33(37)43-6)22(18)15-24(35)29(21)34-23(20)14-19/h7-8,11-12,14,18,22,24,27-28,31,34H,9-10,13,15-16H2,1-6H3/t18-,22+,24-,27-,28+,31+/m1/s1

InChI key

QEVHRUUCFGRFIF-MDEJGZGSSA-N

基因信息

human ... SLC18A2(6571)

正在寻找类似产品? 访问 产品对比指南

一般描述

利血平是一种吲哚生物碱,它不可逆地结合囊泡单胺转运蛋白VMAT1和VMAT2。它是一种可用于治疗系统性高血压的抗交感神经药物。

应用

利血平已被用作性能研究中的测试化学物质。

生化/生理作用

利血平用于治疗妊娠期高血压(hypertensive pregnancy difficulties)。这种药物也是一种抗精神病药和降压药,可调节高血压。
抑制儿茶酚胺和血清素的囊泡摄取。

象形图

Health hazardExclamation mark

警示用语:

Danger

危险分类

Acute Tox. 4 Oral - Carc. 2 - Repr. 1A - STOT SE 3

靶器官

Central nervous system

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

个人防护装备

dust mask type N95 (US), Eyeshields, Faceshields, Gloves

法规信息

监管及禁止进口产品

Choose from one of the most recent versions:

分析证书(COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Heart and circulatory system drugs and diuretics
Drugs During Pregnancy and Lactation, 193-236 (2007)
Intra-laboratory validated human cell-based in vitro vasculogenesis/angiogenesis test with serum-free medium
Toimela T, et al.
Reproductive Toxicology, 70, 116-125 (2017)
What All Should Know about Plant Drugs
Essentials of Biochemistry for Medical Students, 35-61 (2015)
Julia Zwirchmayr et al.
Scientific reports, 10(1), 12323-12323 (2020-07-25)
In this study a robust, whole organism screening based on Caenorhabditis elegans is presented for the discovery of natural products (NP) with beneficial effects against obesity and age-related diseases. Several parameters of the elaborated workflow were optimized to be adapted
Patrizia Spigaglia et al.
Antimicrobial agents and chemotherapy, 53(6), 2463-2468 (2009-04-15)
Recent studies have suggested that exposure to fluoroquinolones represents a risk factor for the development of Clostridium difficile infections and that the acquisition of resistance to the newer fluoroquinolones is the major reason facilitating wide dissemination. In particular, moxifloxacin (MX)

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门